Home > Insider Trading > Filing (0001104659-23-028603)

Filing Details

Accession Number:: 0001104659-23-028603
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-03 20:00:56
Reporting Period:: 2023-02-27

Accepted Time:: 2023-03-03 20:00:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651407	Checkpoint Therapeutics Inc.	CKPT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1434718	Iii F James Oliviero	95 Sawyer Rd, Suite 110 Waltham MA 02453	Ceo, President And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-02-27	5,548	$4.65	134,573	No	4	S	Direct
Common Stock	Acquisiton	2023-02-27	15,000	$0.00	149,573	No	4	A	Direct
Common Stock	Disposition	2023-03-02	5,483	$5.00	144,090	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

In connection with the vesting of 14,950 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $4.65 to $4.6833. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Includes shares of restricted common stock, which vest over various time periods.
Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on February 27, 2023.
In connection with the vesting of 15,000 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $5.00 to $5.03. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.